文献速递乳房整形与再造创面修复显微修复重建

质子与光子乳房切除术后放疗后胸肌前假体乳房重建的修正手术比较

Revision Surgeries After Proton vs Photon Postmastectomy Radiation Therapy in Prepectoral Implant-Based Breast Reconstruction.
PubMed 文献 · Aesthet Surg J · 2025-01-01

单中心回顾性队列研究纳入2020年1月至2022年10月接受乳房切除、胸肌前假体乳房重建及乳房切除术后放疗的乳腺癌患者116例,比较光子放疗(75例,64.66%)与质子放疗(41例,35.34%)后的修正手术。光子组总体修正手术率为32.4%,质子组为19.5%(P=0.132),光子组转为自体皮瓣的几率显著更高(OR=4.55,P=0.025)。作者认为质子治疗更安全且所需修正手术更少,但需更大规模研究。

要点

  • 光子组总体修正手术率为32.4%,质子组为19.5%,差异无统计学意义(P=0.132)。
  • 光子组转为自体皮瓣的几率显著高于质子组(OR=4.55,P=0.025)。
  • 多变量分析中光子组转为自体皮瓣的OR=5.97(P=0.049)。

核心结论

  • 与传统光子治疗相比,质子治疗在胸肌前假体乳房重建中转为自体皮瓣的几率更低;光子治疗总体修正手术率更高但差异无统计学意义。
  • 作者认为质子治疗更安全且所需修正手术更少,并认为需要更大规模研究和更广泛的应用。

研究设计与样本

  • 单中心回顾性队列研究,纳入2020年1月至2022年10月接受乳房切除、胸肌前假体乳房重建及乳房切除术后放疗的乳腺癌患者。
  • 共116例,分为光子放疗组75例(64.66%)和质子放疗组41例(35.34%)。
  • 队列平均随访时间为1056.4天(2.89年)。

主要发现

  • 总体修正手术率:光子组32.4% vs 质子组19.5%(P=0.132)。
  • 任何修正手术的比值比:光子治疗OR=1.98。
  • 转为自体皮瓣的比值比:光子治疗OR=4.55(P=0.025)。
  • 多变量分析:光子治疗患者需要任何修正手术的OR=1.62(P=0.359),自体皮瓣OR=5.97(P=0.049),脂肪移植OR=1.52(P=0.664),瘢痕修整OR=4.51(P=0.273)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postmastectomy radiation therapy (PMRT) improves disease-free survival in breast cancer but reduces aesthetic satisfaction. Proton PMRT has gained popularity because it results in fewer systemic complications. There is a lack of data regarding revision surgeries for prepectoral implant-based breast reconstruction (PP-IBBR) following radiation. OBJECTIVES: The aim of this study was to compare revision surgeries in PP-IBBR with photon vs proton PMRT. METHODS: A single-institution retrospective cohort study was performed that included breast cancer patients undergoing mastectomy and PP-IBBR with PMRT between January 2020 and October 2022. The mean follow-up duration for the cohort was 1056.4 days (2.89 years). Revision surgeries evaluated were fat grafting, conversion to autologous flaps, implant replacement, implant removal, capsulectomy, and scar revision. RESULTS: The 116 PP-IBBR subjects were divided into 2 cohorts, receiving either photon (75, 64.66%) or proton (41, 35.34%) radiation. Overall corrective surgeries were higher with photon therapy (27.5% overall; 32.4% photon vs 19.5% proton, P = .132). The odds of any revision surgery were nearly double with photon therapy (odds ratio [OR] = 1.98), and the conversion to an autologous flap was significantly more likely with photon therapy (OR = 4.55, P = .025). Multivariable analysis showed an increased tendency for photon therapy patients to require any revision surgeries (OR = 1.62, P = .359), autologous flaps (OR = 5.97, P = .049), fat grafting (OR = 1.52, P = .664), and scar revision (OR = 4.51, P = .273). CONCLUSIONS: Compared to proton therapy, traditional photon therapy has a higher conversion rate to autologous flaps with PP-IBBR. Photon therapy had higher rates of overall revision surgeries, but the difference was not statistically significant. Proton therapy is safer and requires fewer revision surgeries, warranting larger studies and broader utilization.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Desai A, Mangal R, Padilla C, et al. Revision Surgeries After Proton vs Photon Postmastectomy Radiation Therapy in Prepectoral Implant-Based Breast Reconstruction. Aesthet Surg J. 2025. PMID: 39431294. doi:10.1093/asj/sjae216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。